22 results
DEFA14A
TYRA
Tyra Biosciences Inc
7 May 24
Additional proxy soliciting materials
4:34pm
information regarding the composition of our Board and its committees, as well as other corporate governance policies, please read the Proxy Statement
8-K
TYRA
Tyra Biosciences Inc
7 May 24
Departure of Directors or Certain Officers
4:29pm
. Rothenberg were effective as of May 7, 2024. These appointments were made based upon the recommendation of the Board’s Nominating and Corporate Governance Committee
PRE 14A
TYRA
Tyra Biosciences Inc
5 Apr 24
Preliminary proxy
4:20pm
and qualified or until such director’s earlier death, resignation or removal. Based on the recommendation of the Nominating and Corporate Governance Committee … Simson, Ph.D.
Director
Nominating and Corporate Governance; Science and Technology (Chair)
Rehan Verjee
Director
Audit (Chair)
CLASS I DIRECTORS—Terms
8-K
EX-3.2
eiwn1w8
26 Oct 23
Amendments to Articles of Incorporation or Bylaws
4:50pm
8-K
EX-3.1
08c ct8k19d
26 Oct 23
Amendments to Articles of Incorporation or Bylaws
4:50pm
DEF 14A
old5ujgv
28 Apr 22
Definitive proxy
4:07pm
10-K
yw2jl0ozm 95wd
3 Mar 22
Annual report
4:31pm
10-Q
p1ilxzzjka97w9
3 Nov 21
Quarterly report
4:31pm
8-K
EX-3.2
58kikjm98gjcu
17 Sep 21
Amendments to Articles of Incorporation or Bylaws
4:01pm
424B4
jqrm vh9laddpy
15 Sep 21
Prospectus supplement with pricing info
4:10pm
S-1/A
EX-10.4
vyak7uhjn
9 Sep 21
IPO registration (amended)
6:08am
S-1/A
g52 d6k5s3w853hlc
9 Sep 21
IPO registration (amended)
6:08am
S-1
byb fj47d7e1d
20 Aug 21
IPO registration
4:07pm
S-1
EX-3.4
vq4ysmoxx0s n9eo59
20 Aug 21
IPO registration
4:07pm